# Gastric Gluten-Degradation Activity of PvP001

> **NCT03594331** · PHASE1 · TERMINATED · sponsor: **Danielle Kim Turgeon** · enrollment: 43 (actual)

## Conditions studied

- Digestive System Disease

## Interventions

- **DRUG:** Low-dose PvP001
- **DRUG:** Medium-dose PvP001
- **DRUG:** High-dose PvP001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03594331
- **Lead sponsor:** Danielle Kim Turgeon
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-25
- **Primary completion:** 2019-02-06
- **Final completion:** 2019-02-06
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Funding stopped
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594331, "Gastric Gluten-Degradation Activity of PvP001". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03594331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*